Monitoring the hydrolyzation of aspirin during the dissolution testing for aspirin delayed-release tablets with a fiber-optic dissolution system
- PMID: 29403772
- PMCID: PMC5760771
- DOI: 10.1016/j.jpha.2012.06.002
Monitoring the hydrolyzation of aspirin during the dissolution testing for aspirin delayed-release tablets with a fiber-optic dissolution system
Abstract
The purpose of this study was to investigate the hydrolyzation of aspirin during the process of dissolution testing for aspirin delayed-release tablets. Hydrolysis product of salicylic acid can result in adverse effects and affect the determination of dissolution rate assaying. In this study, the technique of differential spectra was employed, which made it possible to monitor the dissolution testing in situ. The results showed that the hydrolyzation of aspirin made the percentage of salicylic acid exceed the limit of free salicylic acid (4.0), and the hydrolyzation may affect the quality detection of aspirin delayed-release tablets.
Keywords: Aspirin delayed-release tablets; Drug dissolution test; Fiber-optic dissolution system; UV–vis spectrum.
Figures
References
-
- Khan A., Rahman M., Islam S. Antipyretic activity of Peperomia pellucida leaves in rabbit. Turk. J. Biol. 2008;1(32):37–41.
-
- Erkan D., Harrison M.J., Levy R. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum. 2007;56(7):2382–2391. - PubMed
-
- Sørensen H.T., Mellemkjaer L., Blot W.J. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am. J. Gastroenterol. 2000;95(9):2218–2224. - PubMed
-
- Berges-Gimeno M.P., Stevenson D.D. Nonsteroidal anti-inflammatory drug-induced reactions and desensitization. J. Asthma. 2004;41(4):375–384. - PubMed
LinkOut - more resources
Full Text Sources
